000 | 02019 a2200577 4500 | ||
---|---|---|---|
005 | 20250517155106.0 | ||
264 | 0 | _c20180716 | |
008 | 201807s 0 0 eng d | ||
022 | _a1579-2129 | ||
024 | 7 |
_a10.1016/j.arbres.2017.04.012 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJiménez Ruiz, Carlos A | |
245 | 0 | 0 |
_aUsing PICO Methodology to Answer Questions About Smoking in COPD Patients. _h[electronic resource] |
260 |
_bArchivos de bronconeumologia _cNov 2017 |
||
300 |
_a622-628 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 |
_aBupropion _xeconomics |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 |
_aCounseling _xeconomics |
650 | 0 | 4 |
_aEvidence-Based Medicine _xmethods |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMotivation |
650 | 0 | 4 |
_aNicotine _xeconomics |
650 | 0 | 4 |
_aNicotinic Agonists _xeconomics |
650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xphysiopathology |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aSmoking _xdrug therapy |
650 | 0 | 4 |
_aSmoking Cessation _xeconomics |
650 | 0 | 4 |
_aSpirometry _xpsychology |
650 | 0 | 4 | _aSurveys and Questionnaires |
650 | 0 | 4 |
_aVarenicline _xeconomics |
700 | 1 | _aBuljubasich, Daniel | |
700 | 1 | _aRiesco Miranda, Juan Antonio | |
700 | 1 | _aAcuña Izcaray, Agustín | |
700 | 1 | _ade Granda Orive, José Ignacio | |
700 | 1 | _aChatkin, José Miguel | |
700 | 1 | _aZabert, Gustavo | |
700 | 1 | _aGuerreros Benavides, Alfredo | |
700 | 1 | _aPaez Espinel, Nelson | |
700 | 1 | _aNoé, Valeri | |
700 | 1 | _aSánchez-Angarita, Efraín | |
700 | 1 | _aNúñez-Sánchez, Ingrid | |
700 | 1 | _aSansores, Raúl H | |
700 | 1 | _aCasas, Alejandro | |
700 | 1 | _aPalomar Lever, Andrés | |
700 | 1 | _aAlfageme Michavila, Inmaculada | |
773 | 0 |
_tArchivos de bronconeumologia _gvol. 53 _gno. 11 _gp. 622-628 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.arbres.2017.04.012 _zAvailable from publisher's website |
999 |
_c27224016 _d27224016 |